Profil
Markus Ferrari is the founder of NovaPump GmbH, founded in 2012, and JenaValve Technology GmbH, founded in 2006.
At JenaValve Technology GmbH, he held the title of Director-Executive Board from 2010 to 2011.
Dr. Ferrari is also the founder of JenaValve Technology, Inc. Dr. Ferrari's current job is as the Director-Internal Medicine & Associate Professor at Friedrich Schiller University of Jena, starting in 2011.
Dr. Ferrari obtained a doctorate degree from Friedrich Schiller University of Jena in 1993.
Postes actifs de Markus Ferrari
| Sociétés | Poste | Début |
|---|---|---|
| Friedrich Schiller University of Jena | Corporate Officer/Principal | 31/03/2010 |
NovaPump GmbH
 NovaPump GmbH BiotechnologyHealth Technology NovaPump GmbH develops heart support and biventricular support technologies. It operates in the field of interventional cardiology, with focus on the development of a percutaneous heart support procedure. The firm also focuses on supplementing pump technologies, aimed at achieving higher pumping volume during the treatment of acute heart care cases. The company was founded by Ronald Reich and Markus Ferrari in 2012 and is headquartered in Jena, Germany. | Fondateur | 01/01/2012 |
Anciens postes connus de Markus Ferrari
| Sociétés | Poste | Fin |
|---|---|---|
JenaValve Technology, Inc.
 JenaValve Technology, Inc. Medical SpecialtiesHealth Technology JenaValve Technology, Inc. designs, develops, manufactures, and markets transcatheter aortic valve replacement systems. The company was founded on March 27, 2006 and is headquartered in Wilmington, DE. | Fondateur | - |
JenaValve Technology GmbH
 JenaValve Technology GmbH Medical SpecialtiesHealth Technology JenaValve Technology GmbH develops and manufactures transcatheter valve implantation systems for transapical and transfemoral implantation. The firm offers a therapeutic alternative to surgical aortic valve replacement for high-risk patients suffering from aortic heart valve stenosis. The company was founded by Markus Ferrari, Volker Guyenot and Hans-Reiner Figulla in 2006 and is headquartered in Munich, Germany. | Fondateur | - |
Formation de Markus Ferrari
| Friedrich Schiller University of Jena | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
JenaValve Technology GmbH
JenaValve Technology GmbH Medical SpecialtiesHealth Technology JenaValve Technology GmbH develops and manufactures transcatheter valve implantation systems for transapical and transfemoral implantation. The firm offers a therapeutic alternative to surgical aortic valve replacement for high-risk patients suffering from aortic heart valve stenosis. The company was founded by Markus Ferrari, Volker Guyenot and Hans-Reiner Figulla in 2006 and is headquartered in Munich, Germany. | Health Technology |
JenaValve Technology, Inc.
JenaValve Technology, Inc. Medical SpecialtiesHealth Technology JenaValve Technology, Inc. designs, develops, manufactures, and markets transcatheter aortic valve replacement systems. The company was founded on March 27, 2006 and is headquartered in Wilmington, DE. | Health Technology |
NovaPump GmbH
NovaPump GmbH BiotechnologyHealth Technology NovaPump GmbH develops heart support and biventricular support technologies. It operates in the field of interventional cardiology, with focus on the development of a percutaneous heart support procedure. The firm also focuses on supplementing pump technologies, aimed at achieving higher pumping volume during the treatment of acute heart care cases. The company was founded by Ronald Reich and Markus Ferrari in 2012 and is headquartered in Jena, Germany. | Health Technology |
